Company Spotlight: Akari Therapeutics

Akari Therapeutics PLC (AKTX) has returned an impressive 107% so far this year compared to a modest 8.60% rise in the iShares NASDAQ Biotech Index ETF (IBB) during the same period.

from RTT - Biotech http://ift.tt/2oQ1fnb
via IFTTT